Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies

Wei Shi(The University of Texas MD Anderson Cancer Center), Di Zhao(The University of Texas MD Anderson Cancer Center)

Science Translational Medicine

May 10, 2023

10.1126/scitranslmed.adf6724

Cited by 65

Related Papers

NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells

|Journal of Clinical Investigation|2014|159